Debut Plus

141.08

+6.71 +4.99%

As of 09 Sept 2026 · delayed

NSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
NSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-09-03

Par Drugs & Chemicals Ltd. (PAR)

Volume: 18,033Avg Vol 1W: 1,56,343Avg Vol 1M: 1,67,323.3552W Range:78.05180
Key Ratios
Checked 6h ago
Market Cap₹165 Cr
Current Price₹141.08
Previous Close₹134.37
High / Low (52w)₹180 / ₹78.05
Volume18,033
Avg Vol (1W)1,56,343
Avg Vol (1M)1,67,323.35
Stock P/E11.41
Book Value₹91.01
Dividend Yield0%
ROE11.71%
ROA11.21%
Revenue (TTM)₹103 Cr
Revenue Growth
Profit Margin13.31%
Total Debt₹0 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹11.78
P/B1.48
Debt / Equity0
50 DMA₹105.53
200 DMA₹95.7
Day change+4.99%
SurveillanceESM · ESM 1
Price Chart
141.08 24.30% · 1Y
1687915.1L
2025-09-10
2026-09-09

20-day avg volume: 1.7L shares

Pros
  • Company is almost debt-free.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹35 Cr₹21 Cr₹22 Cr₹26 Cr₹29 Cr₹29 Cr₹20 Cr₹31 Cr
EBITDA₹12 Cr₹1 Cr₹2 Cr₹4 Cr₹6 Cr₹6 Cr₹1 Cr₹6 Cr
Net Profit₹9 Cr₹1 Cr₹2 Cr₹3 Cr₹4 Cr₹5 Cr₹1 Cr₹5 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹42 Cr₹46 Cr₹56 Cr₹61 Cr₹75 Cr₹96 Cr₹96 Cr₹103 Cr
EBITDA₹5 Cr₹5 Cr₹7 Cr₹13 Cr₹13 Cr₹15 Cr₹20 Cr₹18 Cr
Net Profit₹2 Cr₹3 Cr₹5 Cr₹12 Cr₹9 Cr₹11 Cr₹15 Cr₹13 Cr
EPS5.645.67.7518.877.499.2111.7810.86
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹51 Cr₹60 Cr₹76 Cr₹79 Cr₹89 Cr₹102 Cr₹119 Cr₹129 Cr
Total Liabilities₹22 Cr₹20 Cr₹24 Cr₹19 Cr₹18 Cr₹16 Cr₹20 Cr₹17 Cr
Equity₹29 Cr₹41 Cr₹52 Cr₹60 Cr₹71 Cr₹86 Cr₹99 Cr₹112 Cr
Total Debt₹0 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹16 Cr₹11 Cr₹18 Cr₹25 Cr₹21 Cr₹21 Cr
Investing₹0 Cr₹-3 Cr₹-7 Cr₹-6 Cr₹-25 Cr₹-2 Cr
Financing₹2 Cr₹-10 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹16 Cr₹11 Cr₹18 Cr₹25 Cr₹21 Cr₹21 Cr
Shareholding
Promoter 73.41% Institutions 0.09% Public 26.51%
About Par Drugs & Chemicals Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, Alusil, PARSIL-HT, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

www.pardrugs.com
Efficiency & Working Capital
ROCE15.6%
Interest Coverage225.1
Dividend Payout
Debtor Days38 d
Inventory Days17 d
Payable Days26 d
Cash Conversion Cycle29 d
Working Capital Days55 d
Shareholding Details

As of 2026-06-30

Promoter73.4%
FII0%
DII0.1%
Institutions0.1%
Public26.5%
Promoter Pledge0%
No. of Shareholders12,782
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters74.2%74.2%74.2%74.2%73.4%73.4%73.4%73.4%73.4%73.4%73.4%73.4%
FIIs0%0.1%0.1%0.3%0.1%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0.1%
Public25.8%25.7%25.7%25.5%26.5%26.6%26.6%26.6%26.6%26.6%26.6%26.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders5,9027,0207,4038,0228,75717,19915,47214,88714,28013,76113,22212,782
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Jignesh Vallabhbhai SavaniShareholding of Promoter and Promoter Group21.9%26,92,440
Falgun Vallabhbhai SavaniShareholding of Promoter and Promoter Group21.5%26,45,952
Saritaben Vallabhbhai SavaniShareholding of Promoter and Promoter Group20.5%25,25,318
Ghanshayambhai B SavaniShareholding of Promoter and Promoter Group6.5%8,02,284
Econo Trading And Investment Private LimitedPublic Shareholding1.8%2,21,872
Savani Nayna JigneshShareholding of Promoter and Promoter Group1.5%1,89,384
Shilpaben Falgun SavaniShareholding of Promoter and Promoter Group1.4%1,77,372
Rita Haresh RadadiyaShareholding of Promoter and Promoter Group0%0
Savani Devansh FalgunbhaiShareholding of Promoter and Promoter Group0%0
Mihika Falgunbhai SavaniShareholding of Promoter and Promoter Group0%0
Rakesh Balubhai Padariya (huf)Shareholding of Promoter and Promoter Group0%0
Shirish Laxmamrao Padhye And Nom Gases- Proprietorship Of Shirish PadhyeShareholding of Promoter and Promoter Group0%0
Sudha Shirish PadhyeShareholding of Promoter and Promoter Group0%0
Sameer Shirish Padhye And Nshree Packaging- Proprietorship Of Sameer PadhyeShareholding of Promoter and Promoter Group0%0
Aayush Jigneshbhai SavaniShareholding of Promoter and Promoter Group0%0
Jinen Jigneshbhai SavaniShareholding of Promoter and Promoter Group0%0
Govind Jivrajbhai Tarparanand Rajmoti Chemicals Industries -proprietorship Of Govind JivrajShareholding of Promoter and Promoter Group0%0
Dhiraj Govindbhai TarparaShareholding of Promoter and Promoter Group0%0
Vasu PadariyaShareholding of Promoter and Promoter Group0%0
Poonam Nishant PatelShareholding of Promoter and Promoter Group0%0
Payal ViraniShareholding of Promoter and Promoter Group0%0
Savani Falgun Vallabhbhai (huf)Shareholding of Promoter and Promoter Group0%0
Savani Jigneshkumar Vallabhbhai (huf)Shareholding of Promoter and Promoter Group0%0
Ghanshayambhai Bhagvanbhai Savani (huf)Shareholding of Promoter and Promoter Group0%0
Govind Jivraj Tarpara (huf)Shareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
FALGUN VALLABHBHAI SAVANIChairman / Executive Director / M D / Promoter2025
JIGNESHBHAI VALLABHBHAI SAVANIExecutive Director & CEO2025
Krishna Mitulbhai ShahIndependent Non Exe. Director2025
Kajal Chintanbhai VaghaniIndependent Non Exe. Director2025
Pravin Manjibhai BhayaniIndependent Non Exe. Director2025
Bintal Bhaveshkumar ShahIndependent Non Exe. Director2025
Sanket Bhupendrabhai TrivediCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing of API₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10131212
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-22Board Meetings
forthcoming2026-08-08Board Meetings
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000212
2025000011
2025000202
Company Information
Incorporated1999
ChairmanFALGUN VALLABHBHAI SAVANI
AuditorSarupriya Somani & Associates
Investor Email[email protected]
🌐 www.pardrugs.com

📍 805 Dwarkesh Complex, RC Dutt Road Alkapuri, Vadodara, Gujarat, 390007

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search